Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice

The Versatile Effects of Dihydromyricetin in Health

(2017) Hongliang Li et al.   Evidence-based Complementary and Alternative Medicine

Anti-inflammatory effects of dihydromyricetin in a mouse model of asthma

(2017) Bin Xu et al.   Molecular Medicine Reports

Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics

(2016) William James Deardorff et al.   Expert Review of Neurotherapeutics

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

(2016) Marina Saresella et al.   Molecular Neurodegeneration

Dihydromyricetin suppresses inflammatory responsesin vitroandin vivothrough inhibition of IKKβ activity in macrophages

(2016) Rui Wang et al.   SCANNING

Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics

(2016) William James Deardorff et al.   Expert Review of Neurotherapeutics

Macrophage CGI-58 deficiency promotes IL-1β transcription by activating the SOCS3–FOXO1 pathway

(2015) Hongming Miao et al.   CLINICAL SCIENCE

Microglia-Mediated Inflammation and Neurodegenerative Disease

(2015) Ling Xu et al.   MOLECULAR NEUROBIOLOGY

Neuroinflammatory processes in cognitive disorders: Is there a role for flavonoids and n-3 polyunsaturated fatty acids in counteracting their detrimental effects?

(2015) David Vauzour et al.   NEUROCHEMISTRY INTERNATIONAL

β-amyloid, microglia, and the inflammasome in Alzheimer’s disease

(2015) Maike Gold et al.   Seminars in Immunopathology

2014 Alzheimer's disease facts and figures

(2014)   Alzheimers & Dementia

Targeting microglia for the treatment of Alzheimer’s disease

(2014) Patrick L McGeer et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Dihydromyricetin Ameliorates Behavioral Deficits and Reverses Neuropathology of Transgenic Mouse Models of Alzheimer’s Disease

(2014) Jing Liang et al.   NEUROCHEMICAL RESEARCH

Microglia actions in Alzheimer’s disease

(2013) Stefan Prokop et al.   ACTA NEUROPATHOLOGICA

Love and death: microglia, NLRP3 and the Alzheimer's brain

(2013) Tobias Goldmann et al.   CELL RESEARCH

Antimalarial Drug Artemisinin Extenuates Amyloidogenesis and Neuroinflammation in APPswe/PS1dE9 Transgenic Mice via Inhibition of Nuclear Factor-κB and NLRP3 Inflammasome Activation

(2013) Jian-Quan Shi et al.   CNS Neuroscience & Therapeutics

Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease

(2013) Andrea C. Paula-Lima et al.   JOURNAL OF NEUROCHEMISTRY

The NLRP3 Inflammasome in Alzheimer’s Disease

(2013) Meng-Shan Tan et al.   MOLECULAR NEUROBIOLOGY

1-Dehydro-[10]-gingerdione from ginger inhibits IKKβ activity for NF-κB activation and suppresses NF-κB-regulated expression of inflammatory genes

(2012) Hwa Young Lee et al.   BRITISH JOURNAL OF PHARMACOLOGY

Dihydromyricetin As a Novel Anti-Alcohol Intoxication Medication

(2012) Y. Shen et al.   JOURNAL OF NEUROSCIENCE

NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice

(2012) Michael T. Heneka et al.   NATURE

Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers

(2011) E. Sierra-Filardi et al.   BLOOD

Alzheimer's disease

(2011) Clive Ballard et al.   LANCET

The Inflammasomes

(2010) Kate Schroder et al.   CELL

Microglia Activation and Anti-inflammatory Regulation in Alzheimer’s Disease

(2010) Lih-Fen Lue et al.   MOLECULAR NEUROBIOLOGY

Amyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin

(2008) E. Malito et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

The NALP3 inflammasome is involved in the innate immune response to amyloid-β

(2008) Annett Halle et al.   NATURE IMMUNOLOGY